Business
Cardinal Health releases new report on the cell and gene therapy industry
Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (CGTs).
About this update from Cardinal Health, Inc.
[{"type":"text","content":"Analysis charts the emergence and future of advanced therapies","length":62,"tagName":"p","attribs":{}},{"type":"text","content":"DUBLIN, Ohio, May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (CGTs).","length":288,"tagName":"p"},{"type":"image","alt":"Cardinal Health Logo (PRNewsfoto/Cardinal Health)","displaySize":"","headline":null,"caption":"Cardinal Health Logo (PRNewsfoto/Cardinal Health)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/d41800153e4379ebc3be8d7ea14e769a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MGSDCW_NwThVKX4JP5ds_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d41800153e4379ebc3be8d7ea14e769a","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2223684/Cardinal_Health_no_tagline_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"This inaugural report is based on a comprehensive survey of more than 100 healthcare providers as well as interviews with subject matter experts and a patient who received CAR T-cell therapy, all of whom provide valuable insights into the state of the CGT industry.","length":265,"tagName":"p"},{"type":"text","content":""Cell and gene therapies are poised to revolutionize healthcare treatment for a wide range of diseases," said Craig Cowman, EVP, Biopharma Solutions and Strategic Sourcing at Cardinal Health. "They hold the potential to fundamentally improve the lives of patients with cancer, heart disease, diabetes, and hereditary conditions. Our report provides a comprehensive analysis of the industry's current state and the exciting future that lies ahead."","length":471,"tagName":"p"},{"type":"text","content":"The report underscores the transformative potential of CGTs, particularly for patients with complex and rare conditions, and documents one patient's experiences with CAR T-cell therapy, including the challenges he encountered along the way.","length":244,"tagName":"p"},{"type":"text","content":"The advanced therapy industry is poised for rapid gro...